These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 28285296)

  • 1. Is Shorter Treatment Regimen for Multidrug-resistant Tuberculosis feasible in Indian Children?
    Shah I
    Indian Pediatr; 2017 Feb; 54(2):160. PubMed ID: 28285296
    [No Abstract]   [Full Text] [Related]  

  • 2. Resistance profile of drugs composing the "shorter" regimen for multidrug-resistant tuberculosis in Brazil, 2000-2015.
    Dalcolmo M; Gayoso R; Sotgiu G; D'Ambrosio L; Rocha JL; Borga L; Fandinho F; Braga JU; Arakaki Sanchez D; Dockhorn F; Centis R; Migliori GB
    Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28404651
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug-resistant Mycobacterium tuberculosis, Taiwan.
    Jou R; Chuang PC; Wu YS; Yan JJ; Luh KT
    Emerg Infect Dis; 2006 May; 12(5):871-2. PubMed ID: 16710962
    [No Abstract]   [Full Text] [Related]  

  • 4. Emerging resistant clone of Mycobacterium tuberculosis in west Asia.
    Mokrousov I
    Lancet Infect Dis; 2016 Dec; 16(12):1326-1327. PubMed ID: 27998587
    [No Abstract]   [Full Text] [Related]  

  • 5. Practical considerations to implement the shorter regimen to MDR-TB patients in China.
    Liu Q; Sun F; Li Y; Bao J; Zhang Y; Zhang W
    Clin Microbiol Infect; 2018 Oct; 24(10):1035-1036. PubMed ID: 29730223
    [No Abstract]   [Full Text] [Related]  

  • 6. Totally drug-resistant and extremely drug-resistant tuberculosis: the same disease?
    Migliori GB; Centis R; D'Ambrosio L; Spanevello A; Borroni E; Cirillo DM; Sotgiu G
    Clin Infect Dis; 2012 May; 54(9):1379-80. PubMed ID: 22492321
    [No Abstract]   [Full Text] [Related]  

  • 7. High prevalence of multidrug-resistant tuberculosis in Zunyi, Guizhou Province of China.
    Chen L; Li N; Liu M; Zhang J; Zhang H
    J Antimicrob Chemother; 2011 Oct; 66(10):2435-7. PubMed ID: 21795258
    [No Abstract]   [Full Text] [Related]  

  • 8. [Extrapulmonary tuberculosis: situation in the new century].
    García JF
    Enferm Infecc Microbiol Clin; 2008 Nov; 26(9):537-9. PubMed ID: 19100171
    [No Abstract]   [Full Text] [Related]  

  • 9. Infectious disease. Drug-resistant TB on the rise.
    Stokstad E
    Science; 2000 Mar; 287(5462):2391. PubMed ID: 10766610
    [No Abstract]   [Full Text] [Related]  

  • 10. [Shortened, strictly supervised tuberculosis treatment in populations with moderate drug resistance levels: international impact perspective].
    Santos-Preciado JI; Franco-Paredes C
    Rev Invest Clin; 2005; 57(3):488-90. PubMed ID: 16187710
    [No Abstract]   [Full Text] [Related]  

  • 11. Need for Revision of Guidelines for Management of DR-TB in Children.
    Kumari M; Shah I
    Indian Pediatr; 2017 Feb; 54(2):164-165. PubMed ID: 28285302
    [No Abstract]   [Full Text] [Related]  

  • 12. Acquired drug resistance during inadequate therapy in a young child with tuberculosis.
    Garcia-Prats AJ; Willemse M; Seifart HI; Jordaan AM; Werely CJ; Donald PR; Schaaf HS
    Pediatr Infect Dis J; 2014 Aug; 33(8):883-5. PubMed ID: 25222312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen.
    Achar J; Berry C; Herboczek K; Parpieva N; Tillyashaykhov MN; Tigay ZN; Khamraev A; Velivela K; Seddon JA; du Cros P
    Emerg Infect Dis; 2015 Nov; 21(11):2105-6. PubMed ID: 26488556
    [No Abstract]   [Full Text] [Related]  

  • 14. Additional Drug Resistance Patterns among Multidrug-Resistant Tuberculosis Patients in Korea: Implications for Regimen Design.
    Mok JH; Kang BH; Lee T; Lee HK; Jang HJ; Cho YJ; Jeon D
    J Korean Med Sci; 2017 Apr; 32(4):636-641. PubMed ID: 28244290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The "source" of drug-resistant TB outbreaks.
    van Helden PD; Victor T; Warren RM
    Science; 2006 Oct; 314(5798):419-20. PubMed ID: 17053131
    [No Abstract]   [Full Text] [Related]  

  • 16. Dynamics of multidrug resistant tuberculosis in Veracruz, México between 2002 and 2008.
    Zenteno-Cuevas R; Rubi A; Fuentes-Dominguez J; Lara-Gonzalez JL; Escobar-Mesa A
    J Infect Dev Ctries; 2010 Nov; 4(11):776-8. PubMed ID: 21252458
    [No Abstract]   [Full Text] [Related]  

  • 17. Multidrug resistant tuberculosis: a continuing crisis.
    Burki T
    Lancet Infect Dis; 2016 Dec; 16(12):1337-1338. PubMed ID: 27998601
    [No Abstract]   [Full Text] [Related]  

  • 18. Managing drug-resistant tuberculosis: experiences from India.
    Katoch VM
    Expert Rev Anti Infect Ther; 2010 May; 8(5):493-6. PubMed ID: 20455676
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug resistance to the first line of antitubercular regimen (a preliminary report).
    Varaiya A; Gogate A
    Indian J Public Health; 1998; 42(4):126-30. PubMed ID: 10389525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculosis drug resistance: summary report for 2003.
    Can Commun Dis Rep; 2004 May; 30(10):93-5. PubMed ID: 15174496
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.